Collaboration - May 8, 2015
Ardelyx, AZ to Review Agreement
Shares of Ardelyx dropped in after-market trading earlier this week after the AstraZeneca partner acknowledged that its lead drug tenapanor was unimpressive in a Phase IIa study. Ardelyx, based in California, says that tenapanor missed the primary endpoint among 154 patients with Stage 3 chronic kidney disease (CKD) and Type 2 diabetes, and was unable […]
Collaboration - April 2, 2015
New Partner for NeuroVive
NeuroVive Pharmaceutical AB has formed a new partnership with the UK’s Isomerase Therapeutics to pursue a new phase based on new molecules for its stroke medication candidate NVPO14. NeuroVive ended its previous collaboration with to-BBB of the Netherlands at the end of 2014, following to-BBB’s restructuring and liquidation. The partnership with to-BBB was funded through a grant […]
Acquisition - March 19, 2015
Recipharm, Adroit Form Partnership
Recipharm AB and Adroit Science AB have formed a strategic partnership. The companies plan to combine their expertise in formulation development, API development, chemical analysis and other areas to reduce time and cost of development while improving quality. “I very much look forward to cooperation,” says Carl-Johan Lever, executive vice president, development & technology at […]
Business article - January 20, 2013
Private-Public Partnership in Hospitals. The way of the future?
At the moment, one of the largest and most advanced hospital projects in the world is being built in Sweden. The construction of the New Karolinska Solna hospital is being organized as a private-public partnership, the country’s first healthcare private-public partnership project. The new karolinska solna (NKS) is the one of the largest projects ever […]
